Edwards TAVR
@Edwards_TAVR
Followers
2,837
Following
91
Media
409
Statuses
501
Proudly providing the cardiology community with the latest insights and resources on all things TAVR. This page is intended for U.S. health care professionals.
United States
Joined July 2019
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Project 2025
• 420748 Tweets
石丸構文
• 91112 Tweets
CONGRATULATIONS JIMIN
• 67808 Tweets
Parkinson
• 65820 Tweets
Big Boy
• 48335 Tweets
Luna Bella
• 43907 Tweets
Djokovic
• 38941 Tweets
PROUD OF YOU JIMIN
• 32348 Tweets
Novak
• 31161 Tweets
Rune
• 30912 Tweets
Wanda
• 27975 Tweets
不要不急の外出
• 26485 Tweets
Branthwaite
• 20146 Tweets
#ラヴィット間違い探し
• 18580 Tweets
Doja
• 17354 Tweets
プール中止
• 10900 Tweets
花江ちゃん
• 10630 Tweets
As the only valve approved for aortic THV-in-THV,* Edwards
#SAPIEN3
#TAVR
can be used to take control for the future of your patients. Learn about the
#SAPIEN3Ultra
valve, designed to meet your Higher Standard.
#cardioTwitter
#hearthealth
#medEd
1
8
105
Now indicated to treat high or greater surgical risk patients with aortic THV-in-THV, Edwards
#SAPIEN3
#TAVR
allows you to take control for the future of your patients. Learn about achieving your Higher Standard with the
#SAPIEN3
Ultra valve.
#heartnews
0
11
85
#SAPIEN3
#TAVR
is now approved for treatment of severe symptomatic
#aorticstenosis
in low-risk patients. Learn more at
0
27
62
Learn how the Edwards
#SAPIEN3Ultra
valve facilitates future coronary access so you can preserve your
#TAVR
patients' future treatment options.
#hearthealth
#cardioTwitter
#medEd
#heartnews
#medTwitter
#cardioEd
#patient
#severeaorticstenosis
6
14
60
The lifetime management of your
#TAVR
patients is increasingly important. That's your Higher Standard. Now approved to treat ≥ high surgical risk patients w/ aortic THV-in-THV, the Edwards
#SAPIEN3Ultra
valve can be used today & in the future. Learn more.
1
5
47
With the
#LowRisk
patient floodgates opening, what is your hospital's primary goal for optimizing the
#CarePathway
?
#TAVR
#EdwardsBenchmark
#EdwardsLifesciences
#TCT2019
Improve outcomes
160
Keep pace with innovation
55
Increase program capacity
101
Reduce costs
100
0
7
31
As shared during
#TCT2020
, elevated
#echoderivedgradients
for 20mm Edwards
#SAPIEN3Ultra
valves did not correlate to worsening mortality, QoL, NYHA class, or hospital readmission at 1 yr. Read the full abstract by Dr. Eng et al for details.
#TAVR
#medEd
2
7
28
Dear doctors—this
#VALVEntinesDay
, continue to show your patients how much you care by encouraging them to screen for
#HeartValveDisease
. It only takes a moment to send a Valventine’s Day card. Get started at .
0
3
31
The next innovation in
#TAVR
is here. Introducing SAPIEN 3 Ultra RESILIA valve. Together, we’re taking TAVR further.
Learn more at
#RESILIA
#takingTAVRfurther
#SAPIEN3UltraRESILIA
#cardiovascular
#cardiotwitter
0
6
21
The valve you choose for first-time
#TAVR
can affect your patients' future treatment options. First-time TAVR with the Edwards
#SAPIEN
valve is associated with more favorable coronary access post-TAVR-in-TAVR. Find out more.
#cardioTwitter
#heartnews
1
6
20
Welcome to the official Twitter handle for
#EdwardsLifesciences
#TAVR
information. We're dedicated to delivering you helpful practice resources including our Edwards insights on the TAVR industry. Follow us for continued information.
0
5
21
0
8
18
Designed to minimize
#PVL
, our
#EdwardsS3U
valve features a ~40% taller, textured PET outer skirt (compared to
#EdwardsS3
). See the impact S3U is having on
#PVL
, as demonstrated in the
#SAPIEN3Ultra
Study.
1
6
17
With the unprecedented outcomes from the
#PARTNER3
trial, you have the power to change your treatment approach for low-risk patients with severe symptomatic
#aorticstenosis
. Get your
#TAVR
resource here.
#CardioTwitter
#cardioEd
0
7
17
Did you know that data is now available on the Edwards
#SAPIEN3
valve in low-risk
#bicuspid
patients? View the new results for bicuspid patients from the PARTNER 3 Trial to learn more.
#TAVR
#cardioTwitter
#MedEd
#patients
#hearthealth
#cardioEd
0
9
15
The
#SAPIEN3
Ultra valve is built on our proven SAPIEN valve platform. But how does it perform? Tune in during
#TVT2020
for the latest
#S3UltraValve
data. Presentation on Saturday @ 8 am EST by Tamim M. Nazif, MD, moderated by Sunil V. Rao, MD, FSCAI.
#TAVR
#cardioTwitter
#medEd
0
8
14
Late-breaking: PARTNER II Trial 5-yr data supports Edwards
#SAPIEN3
#TAVR
as an excellent alternative to surgery with outstanding durability. Watch the original data presentation from
#TVT2020
.
#cardioTwitter
#cardioEd
#medtwitter
#medEd
#heartnews
0
12
14
PARTNER 3 Trial 2-year data shows excellent outcomes for
#TAVR
with the Edwards
#SAPIEN3
valve, including sustained superiority benefit over surgery for the primary endpoint in low-risk symptomatic severe
#aorticstenosis
patients.
#cardioTwitter
#heartnews
#medEd
#cardioEd
1
7
15
#EdwardsLifesciences
would like to express our gratitude to the global healthcare community, including HCPs and our employees for their dedication to serving patients during this challenging time. We appreciate the strong leadership and commitment of those on the front lines.
0
3
14
Outstanding valve durability. That's one of the takeaways from PARTNER II Trial 5-yr data, which showed excellent clinical performance for Edwards
#SAPIEN3
#TAVR
across key endpoints. Watch the original data presentation from
#TVT2020
.
#cardioTwitter
0
9
13
A difference you can see, the
#SAPIEN3UltraRESILIA
valve is the only
#THV
with unique dry tissue storage.
Learn more about the latest
#SAPIEN
innovation at
#SAPIEN3Ultra
#RESILIA
#TAVR
#takingTAVRfurther
#cardiovascular
#cardiotwitter
0
4
12
The Edwards
#SAPIEN3
transcatheter heart valve is now an approved option for your patients with dysfunctional right ventricular outflow tract (RVOT) conduit or surgical bioprosthetic pulmonic valve in need of intervention.
#COMPASSIONS3
#TPVR
#pulmonic
1
7
12
Edwards
#SAPIEN3
#TAVR
provides excellent results, including low rates of mortality, stroke and PVL at 30 days for low-risk
#bicuspid
patients. View these and other key outcomes to stay current with our latest clinical evidence.
#cardioTwitter
#cardioEd
0
5
12
How are you managing
#TAVR
and
#CAD
in this new age of severe
#AorticStenosis
treatment? Join the symposium on 9/27 (Friday) 4:00pm to 5:30pm Moscone North, Hall F Register:
#TCT2019
0
4
12
In our ongoing commitment to minimize paravalvular leak (
#PVL
), the Edwards
#SAPIEN3Ultra
valve features a ~40% taller outer skirt compared to the Edwards
#SAPIEN3
valve. Early PVL data shows 0% ≥ moderate leak at 30 days.
#TAVR
#cardioTwitter
#medEd
1
5
12
In four days, learn why four fewer days makes a difference to
#LowRisk
#AorticStenosis
patients and how
#cardiologists
like you can guide them there with
#TAVR
. Join us for an
#ACC20
virtual event and experience the
#JourneytoTAVR
#EdwardsLifesciences
#ACC2020
#vhdAS
0
4
12
Almost time for
#TCT2019
& we’re looking forward to seeing our great
#TAVR
community. Who in the
#Twitterverse
is planning to attend?
0
4
12
Edwards
#SAPIEN3
#TAVR
and Edwards
#SAPIEN3Ultra
TAVR had similar, excellent 30-day outcomes. The
#S3Ultra
valve was associated with 0.5% mod/severe PVL.
#cardioTwitter
#cardioEd
#medtwitter
#medEd
#heartnews
#hearthealth
#aorticstenosis
0
7
11
Your low-risk patients are often younger, healthier and more active. Are you ready to meet their needs? See the evolution of patient characteristics.
#PARTNER3
#CardioTwitter
#TAVR
#cardioEd
#treatment
0
5
11
#TVT2020
was certainly a different format vs. years past, but we're happy to have been able to share our data just the same. See the valve-in-surgical valve performance data that was presented for the
#SAPIEN3
valve.
#TAVR
#cardioTwitter
#medEd
0
5
11
Moderate and greater paravalvular leak (PVL) is associated with increased mortality and rehospitalization.* That's why we've been working tirelessly to improve ≥ moderate PVL, as shown in the
#PARTNER
trials.
#TAVR
#cardioTwitter
#medEd
#hearthealth
0
7
11
Designed with your higher standard in mind, the Edwards
#SAPIEN3Ultra
valve is a nominee for the Prix Galien USA "Best Medical Technology" award, which recognizes achievements that improve the human condition. Winners to be announced tomorrow!
#TAVR
0
6
11
Edwards
#SAPIEN3
#TAVR
was proven superior to surgery for the outcomes that matter to your low-risk symptomatic severe
#aorticstenosis
patients.*
#severeaorticstenosis
#medTwitter
#cardioEd
#patient
#hearthealth
#cardioTwitter
#heartnews
0
7
11
We’re happy to announce the 29mm valve size is now available and includes the same
#PVL
outer skirt technology as the rest of our
#SAPIEN3UltraValves
.
Learn more about the latest
#SAPIEN
innovation at
#SAPIEN3UltraRESILIA
#TAVR
#takingTAVRfurther
#TAVR
0
2
11
The latest valve-in-surgical valve performance data for Edwards
#TAVR
is out! Check out the presentation from TVT Connect for the latest.
#TVT2020
#cardioTwitter
#cardioEd
#medtwitter
#medEd
#heartnews
#hearthealth
#aorticstenosis
0
5
10
Now FDA approved! The Edwards
#SAPIEN3
transcatheter heart valve is now approved for transcatheter pulmonic valve replacement (
#TPVR
). Find out how your pediatric and adult patients may benefit from this transcatheter technology.
#COMPASSIONS3
#cardioEd
0
5
10
#valvechoice
matters for future
#coronaryaccess
. The Edwards
#SAPIEN3Ultra
valve was designed with a low frame height and large cell design to easily facilitate future access.
#TAVR
#cardioTwitter
#medEd
#hearthealth
#heartnews
#medTwitter
#cardioEd
0
7
10
Thank you for joining us during
#TVT2020
! We are grateful for the investigators and Dr. Abbas,
@SusheelKodaliMD
,
@tnazifMD
&
@kalazizimd
who shared our late-breaking clinical science, including data for Edwards
#SAPIEN3
#TAVR
and
#SAPIEN3Ultra
TAVR.
#medEd
0
7
10
#SAPIEN3
#TAVR
is now approved for treatment of severe symptomatic
#aorticstenosis
in low-risk patients. Learn more about the groundbreaking
#PARTNER3
data
0
3
9
Preserve your
#TAVR
patients future treatment options by choosing the Edwards
#SAPIEN3Ultra
valve, designed with features that facilitate future coronary access and that may be preferred for accessing the coronaries post-TAVR-in-TAVR. See the data.
0
4
10
We’re live at
#picsymposium2022
. Experience the future of
#TPVR
via a hands-on interactive demo of the new Edwards
#SAPIEN3
TPV system with
#Alterra
adaptive prestent.
⚠️ Important Safety Info
#cardioTwitter
#hearthealth
#medEd
0
3
10
The
#SAPIEN3Ultra
valve is now powered by
#RESILIA
tissue, the same tissue technology used in the
#1
implanted surgical valve in the US. The
#SAPIEN3UltraRESILIA
valve is taking
#TAVR
further, so your patients can go farther.
Learn more at
#SAPIEN
#THV
0
3
10
>60% of the population over the age of 65 live closer to a PCI-only center, so choosing a valve today that can facilitate future coronary access tomorrow matters. Learn about Edwards
#SAPIEN3Ultra
#TAVR
.
#cardioTwitter
#medTwitter
#hearthealth
#medEd
0
6
10
Thank you to our clinician partners for making Edwards
#TAVR
what it is today! We have a special video message from Larry L. Wood and Marty B. Leon, celebrating 10 years of the
#SAPIEN
valve.
#10YearsofTAVR
#cardioTwitter
#medEd
#heartnews
#cardioEd
0
4
9
Mod/severe paravalvular leak (PVL) is associated with increased mortality in severe
#aorticstenosis
patients post-
#TAVR
.* That's why we are proud to share that the
#PARTNER3
Trial demonstrated only 0.6% mod/severe PVL at 1 year (similar to surgery!).
0
4
9
Is echo an accurate way to measure indexed EOA post-
#TAVR
? As shared during
#TCT2020
, EOAi derived by echo in normal flow rates overestimates the incidence and severity of PPM after TAVR and SAVR. Read the abstract by Dr. Amr Abbas for more.
#medTwitter
0
5
9
Edwards
#SAPIEN3
#TAVR
facilitates future coronary access, with 100% post-TAVR coronary access success (n=68/68). Learn more about the valve that allows you to meet your Higher Standard for your patients.
#hearthealth
#cardioEd
#medEd
#cardioTwitter
0
7
9
Late-breaking: PARTNER II Trial 5-yr data supports Edwards
#SAPIEN3
#TAVR
as an excellent alternative to surgery with outstanding durability. Watch the original data presentation from
#TVT2020
.
#cardioTwitter
#cardioEd
#medtwitter
#medEd
#heartnews
0
5
9
Procedural outcomes for the Edwards SAPIEN 3 valve were excellent in low-risk bicuspid patients. See what
#SAPIEN3
#TAVR
can bring to your low-risk
#bicuspid
procedures.
#cardioTwitter
#heartnews
#hearthealth
#medEd
#aorticstenosis
#cardioEd
#medTwitter
0
8
9
Our
#Edwards
#SAPIEN3Ultra
valve is an evolution of the
#SAPIEN3
valve you know and trust. We're committed to innovation, and this is our next step. More on
#S3U
on the
#EdwardsCommander
delivery system here:
0
3
9
Join us at the Edwards Lifesciences virtual event on March 27-30 and get to know the new faces of
#TAVR
. See you soon!
#ACC20
#newfacesofTAVR
0
3
8
Thanks to your dedication, 1M patients worldwide have now been treated with the Edwards SAPIEN platform. Today, we're sharing stories of lives changed, and we welcome you to join in.
Watch & share with us the impact it's had on you & your patients
#ForTheMillionsMore
0
7
9
Visit our booth to learn how we are committed to expanding Edwards
#SAPIEN3
#TPVR
to more
#pulmonic
patients with the
#Alterra
adaptive prestent.
#picsymposium2022
⚠️ Important Safety Info
#cardioTwitter
#pulmonicvalve
#medEd
0
1
8
RESILIA tissue is our proprietary tissue technology that uses a stable-capping process to block calcium from binding to the tissue.*1 This latest innovation offers a unique solution to take
#TAVR
further so your patients can go farther.
Learn more at
0
4
8
At
#Edwards
, your
#patients
are our priority. That's why
#Edwards
has been working hard across our
#PARTNER
trials to reduce paravalvular leak.
#TAVR
#cardioTwitter
#medEd
#cardioEd
#medTwitter
#aorticstenosis
#heartnews
#hearthealth
0
5
8
The 2020
#ACCAHA
Guideline for the Management of Patients with
#Valvular
#HeartDisease
has arrived. Recommendations align more closely with the treatment landscape of today, including more emphasis on
#transcatheter
options like
#TAVR
. See the updates.
2
2
8
Faster AVR procedures are possible with Edwards
#SAPIEN3
#TAVR
, so you can achieve your Higher Standard of treating more patients in a single day. See the data to find out how procedure times for SAPIEN 3 TAVR compare to SAVR.
#cardioTwitter
#heartnews
0
4
8
First valve choice needs to consider the prevalence of CAD risk & future
#TAVRinTAVR
. Edwards
#SAPIEN3Ultra
#TAVR
is approved for THV-in-THV & facilitates future coronary access, allowing you to preserve future treatment options when used first. See more.
0
5
8
Your
#severeaorticstenosis
patients undergoing
#TAVR
may need future
#TAVRinTAVR
& intervention for CAD, so first valve choice is critical. Choose Edwards
#SAPIEN3
Ultra TAVR first to preserve future treatment options & facilitate future coronary access.
0
3
8
Just in from
#TCT2020
: Elevated
#echoderivedgradients
& severe PPM have no impact on clinical outcomes* @ 1yr in all
#TAVR
balloon-expandable valve sizes. Read the related abstract by Dr. Eng with supporting data available now on the
#TCTConnect
website.
0
7
8
Future interventions are an important consideration for
#TAVR
patients. Amr E. Abbas, MD, will be sharing data for
#SAPIEN3
valve-in-surgical valve procedures during
#TVT2020
on Saturday @ 8 am EST.
#TAVR
#cardioTwitter
#medEd
#cardioEd
#hearthealth
0
6
8
The
#LivingProof
is in the Guideline. Today’s
#ACCAHA
Valvular Guideline reflects the expanding indications of
#TAVR
over recent years and also recognizes the benefits associated with TAVR, independent of surgical risk, within supportive text.
0
4
4
Do you factor
#echoderivedgradients
and
#truecathgradients
into your
#TAVR
choice? Tune in to
#PCRValves
on Nov. 24 @ 6:15AM EST to learn more about the limitations of echo. Thank you
@VDelgadoGarcia
for leading the discussion.
#cardioTwitter
#hearthealth
#heartnews
#medEd
Do you want to know the difference between echo and cath for transcatheter valve assessment? join us at
#PCRValves
@PCRonline
0
13
65
0
8
8
Welcome to the
#EdwardsLifesciences
virtual event for
#ACC20
. The door is now open for
#LowRisk
severe
#AorticStenosis
patients and you hold the key. Come to our online experience to meet the new faces of TAVR.
#newfaceofTAVR
#WCCardio
@ACCinTouch
0
7
8
Our next innovation is here: the Edwards
#SAPIEN3Ultra
valve. Get to know
#S3Ultra
#TAVR
.
#cardioTwitter
#medEd
#cardioEd
#medTwitter
#aorticstenosis
#heartnews
#hearthealth
2
5
8
The prevalence of
#CAD
in
#TAVR
patients is causing physicians to re-evaluate their
#valvechoice
. Find out how
#Edwards
#SAPIEN3
#TAVR
facilitates future
#CoronaryAccess
.
0
4
7
How you manage your patients' severe aortic stenosis (
#SAS
) today can impact future
#coronaryaccess
. The good news is, the Edwards
#SAPIEN3
valve is engineered for the future. Learn more.
#TAVR
#cardioTwitter
#hearthealth
#heartnews
#medEd
#cardioEd
0
6
7
Up to 75% of
#severeaorticstenosis
patients are at risk of CAD requiring future coronary intervention. Choose the Edwards
#SAPIEN3Ultra
valve for first-time
#TAVR
to preserve your patients' future treatment options.
0
3
6
Attend the Late Breaker Clinical Trial Abstract Presentations tomorrow at PICS LIVE at 8:20 a.m. EST to discover the two-year outcomes from the
#Alterra
clinical trial.
#TPVR
#WCPCCS2023
0
3
7
Take control for the future with Edwards
#SAPIEN3
#TAVR
, demonstrating
#echoderivedgradients
equivalent to SAVR at 5 years. See the data that shows the excellent clinical outcomes and low SVD rates with low and stable gradients.
#medEd
#cardioTwitter
0
4
6
Today is Heart
#ValveDiseaseDay
. Thank you for the incredible work you do to guide patients to the treatment they need. Your ongoing effort in diagnosing patients with aortic stenosis, the most common type of heart valve disease, has saved lives.
0
1
7
Make sure to join in the
#EdwardsLifesciences
virtual event and experience how you can open the door for your
#LowRisk
severe
#AorticStenosis
#patients
.
#newfaceofTAVR
#vhdAS
0
5
7
Thinking about the future of your patients who may need coronary intervention post-
#TAVR
is your Higher Standard. The Edwards
#SAPIEN3Ultra
valve facilitates future coronary access, allowing you to preserve future treatment options. See the data.
#medEd
0
3
7
Amr E. Abbas, MD, will be presenting the following late-breaker at TVT Connect: Valve-in-Surgical Valve with
#SAPIEN3
for Transcatheter Aortic Valve Replacement. Stream it live on Saturday @ 8 am EST.
#TVT2020
#TAVR
#cardioTwitter
#medEd
#cardioEd
#hearthealth
#S3
#cardiology
0
7
7
Time is valuable in the OR. Our tried and true Edwards Commander Delivery System keeps you efficient, delivering consistent deployment with 99% first-time accuracy.*
#TAVR
#heartnews
#cardioTwitter
#medEd
#hearthealth
#cardioEd
#aorticstenosis
0
5
7
Building on the benefits of the
#SAPIEN
platform which delivers superior outcomes for your patients, the
#SAPIEN3UltraRESILIA
valve is now powered by
#RESILIA
tissue. Together, we’re taking
#TAVR
further.
Learn more at
#RESILIA
#THV
#takingTAVRfurther
0
2
7
Edwards
#SAPIEN3
#TAVR
is striving to to reach your higher standards so you can deliver the outcomes you demand. Learn how
#SAPIEN3
#TAVR
is elevating expectations.
#hearthealth
#cardiotwitter
#medEd
#heartnews
#MedTwitter
#medEd
0
5
7
Attendees are loving what the
#EdwardsBenchmark
symposium is covering -- still a few seats left in our second session from 2:00-3:30
#TAVR
#EdwardsLifesciences
#TCT2019
0
2
7
Recent
@CMSGov
guidelines help you prioritize
#patients
who require non-essential elective
#aorticvalve
replacement procedures. Your severe
#symptomatic
#aorticstenosis
#patients
look to you for your knowledge and expertise. Access resources here
#TAVR
0
3
7